An Anti-hTNF-a Variable New Antigen Receptor Format Demonstrates Superior in vivo Preclinical Efficacy to Humira® in a Transgenic Mouse Autoimmune Polyarthritis Disease Model (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2019.00526
PubMed Identifier: 30967865
Publication URI: http://europepmc.org/abstract/MED/30967865
Type: Journal Article/Review
Parent Publication: Frontiers in Immunology
ISSN: 1664-3224